Publications by authors named "Benjamin Maughan"

49Publications

Comparative Effectiveness of Immune Checkpoint Inhibitors in Patients with Platinum-Refractory Advanced Urothelial Carcinoma.

J Urol 2020 Oct 20:101097JU0000000000001412. Epub 2020 Oct 20.

Division of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JU.0000000000001412DOI Listing
October 2020

Recent developments in the treatment of non-metastatic castration resistant prostate cancer.

Cancer Treat Res Commun 2020 22;24:100181. Epub 2020 May 22.

University of Utah Hospital, UT 84103, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2020.100181DOI Listing
May 2020

Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma.

Cancer Manag Res 2020 20;12:3741-3749. Epub 2020 May 20.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CMAR.S202973DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246323PMC
May 2020

Definitive Chemoradiotherapy for Locally Advanced, Lymph-node Positive, Nonmetastatic Penile Squamous Cell Carcinoma.

Clin Genitourin Cancer 2020 Oct 3;18(5):e573-e584. Epub 2020 Mar 3.

Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2020.02.007DOI Listing
October 2020

Does sequencing order of antiandrogens in prostate cancer matter?

Nat Rev Urol 2020 04;17(4):197-198

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41585-020-0289-9DOI Listing
April 2020

What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing.

Prostate 2020 04 6;80(5):441-450. Epub 2020 Feb 6.

Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23959DOI Listing
April 2020

Patterns of treatment in metastatic renal cell carcinoma for older versus younger patients.

J Geriatr Oncol 2020 May 8;11(4):724-726. Epub 2019 Aug 8.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2019.07.002DOI Listing
May 2020

Treatment Decisions for Metastatic Clear Cell Renal Cell Carcinoma in Older Patients: The Role of TKIs and Immune Checkpoint Inhibitors.

Drugs Aging 2019 05;36(5):395-401

Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope Dr, Suite 2161, Salt Lake City, UT, 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40266-019-00644-1DOI Listing
May 2019

Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and time.

Cancer Treat Res Commun 2019 6;19:100120. Epub 2019 Feb 6.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope Drive Suite 5726, Salt Lake City, UT 84112, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2019.100120DOI Listing
September 2019

Management of Nonmetastatic Castration-Resistant Prostate Cancer: Recent Advances and Future Direction.

Curr Treat Options Oncol 2019 02 11;20(2):14. Epub 2019 Feb 11.

Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-019-0611-zDOI Listing
February 2019

Germline Variant in and Response to Abiraterone Acetate Plus Prednisone (AA) in New-onset Metastatic Castration-resistant Prostate Cancer (mCRPC).

Mol Cancer Ther 2019 03 26;18(3):726-729. Epub 2018 Dec 26.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-18-0739DOI Listing
March 2019

Unclassified renal cell carcinoma: diagnostic difficulties and treatment modalities.

Res Rep Urol 2018 15;10:205-217. Epub 2018 Nov 15.

Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
https://www.dovepress.com/unclassified-renal-cell-carcinoma-
Publisher Site
http://dx.doi.org/10.2147/RRU.S154932DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248403PMC
November 2018

Overview of Current and Future First-Line Systemic Therapy for Metastatic Clear Cell Renal Cell Carcinoma.

Curr Treat Options Oncol 2018 01 24;19(1). Epub 2018 Jan 24.

Department of Oncology, Huntsman Cancer Institute, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-018-0517-1DOI Listing
January 2018

p53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancer.

Prostate Cancer Prostatic Dis 2018 06 4;21(2):260-268. Epub 2018 Jan 4.

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41391-017-0027-4
Publisher Site
http://dx.doi.org/10.1038/s41391-017-0027-4DOI Listing
June 2018

Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate Cancer.

Clin Genitourin Cancer 2017 Sep 6. Epub 2017 Sep 6.

Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.08.017DOI Listing
September 2017

PD-1 checkpoint inhibition: Toxicities and management.

Urol Oncol 2017 12 8;35(12):701-707. Epub 2017 Sep 8.

Department of Internal Medicine, University of Utah, Salt Lake City, UT. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2017.08.005DOI Listing
December 2017

A More Common Massive Retroperitoneal Mass.

JAMA Surg 2017 08;152(8):802-803

Huntsman Cancer Institute, University of Utah, Salt Lake City.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamasurg.2017.0546DOI Listing
August 2017

Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer: A Retrospective Study.

Prostate 2017 01 16;77(1):33-40. Epub 2016 Aug 16.

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pros.23246
Publisher Site
http://dx.doi.org/10.1002/pros.23246DOI Listing
January 2017

A Potential Predictive Role for Prostate-specific Antigen Changes at 4 Weeks?

Eur Urol 2016 11 5;70(5):732-733. Epub 2016 Apr 5.

Genitourinary Oncology Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.03.032DOI Listing
November 2016

Clinical Relevance of Androgen Receptor Splice Variants in Castration-Resistant Prostate Cancer.

Curr Treat Options Oncol 2015 Dec;16(12):57

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, 1650 Orleans Street, CRB1-1M45, Baltimore, MD, 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-015-0375-zDOI Listing
December 2015

Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer.

Prostate 2015 Nov 26;75(15):1814-20. Epub 2015 Aug 26.

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23064DOI Listing
November 2015

Androgen pathway resistance in prostate cancer and therapeutic implications.

Expert Opin Pharmacother 2015 12;16(10):1521-37. Epub 2015 Jun 12.

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center , 1650 Orleans St. CRB1 186, Baltimore, MD USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2015.1055249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696015PMC
November 2015

Enzalutamide in chemo-naïve castration-resistant prostate cancer: effective for most but not for all.

Asian J Androl 2014 Nov-Dec;16(6):807-8

Prostate Cancer Research Program, Department of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/1008-682X.137680DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236319PMC
May 2015

Primary small cell neuroendocrine carcinoma of paranasal sinuses.

Case Rep Med 2014 25;2014:874719. Epub 2014 Jun 25.

Sidney Kimmel Comprehensive Cancer Center, John Hopkins University, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/874719DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095648PMC
July 2014

Emerging molecularly targeted therapies in castration refractory prostate cancer.

Prostate Cancer 2013 8;2013:981684. Epub 2013 May 8.

Division of Medical Oncology, University of UT Huntsman Cancer Institute, Salt Lake City, Utah 84112, USA.

View Article

Download full-text PDF

Source
http://downloads.hindawi.com/journals/pc/2013/981684.pdf
Web Search
http://www.hindawi.com/journals/pc/2013/981684/
Publisher Site
http://dx.doi.org/10.1155/2013/981684DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684034PMC
July 2013